| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/24/2008 | WO2008020126A3 Supramolecular co-colloids produced using macrocyclic polyanionic systems |
| 04/24/2008 | WO2007150075A3 Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone |
| 04/24/2008 | WO2007147116A3 Vaginal drug delivery system and method |
| 04/24/2008 | WO2007146319A9 Methods and apparatus for using polymer-based beads and hydrogels for cardiac applications |
| 04/24/2008 | WO2007144082A3 Combination antihypertensive wafer |
| 04/24/2008 | WO2007144080A3 Combination antidepressants wafer |
| 04/24/2008 | WO2007133750A3 Encapsulated nanoparticles for drug delivery |
| 04/24/2008 | WO2007133514A3 Photosensitizer formulations for topical applications |
| 04/24/2008 | WO2007130566A9 Lumen-traveling biological interface device |
| 04/24/2008 | WO2007115305A3 Oral dosage forms including an antiplatelet agent and an acid inhibitor |
| 04/24/2008 | WO2007110778A3 Mucosal bioadhesive slow release carrier for delivering active principles |
| 04/24/2008 | WO2007106960A9 Controlled-release floating dosage forms |
| 04/24/2008 | WO2007103294A3 Nanoemulsions of poorly soluble pharmaceutical active ingredients and methods of making the same |
| 04/24/2008 | WO2007078765A3 High-throughput fabrication of microparticles |
| 04/24/2008 | WO2007052299B1 Controlled release formulation |
| 04/24/2008 | WO2006093969A3 Particles with high internal pressure for tissue ablation |
| 04/24/2008 | US20080097295 Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, nose and/or throat |
| 04/24/2008 | US20080096978 Hydrogen peroxide, sodium perborate, sodium peroxide or urea peroxide, a non-clouding stabilizer chosen from diethylene triamine penta(methylene phosphonic acid) and 1-hydroxyethylidene-1,1-diphosphonic acid, and hydroxypropyl methyl cellulose and sodium carboxymethyl cellulose |
| 04/24/2008 | US20080096952 Methods for the treatment of atherosclerosis, using substituted phenethylsulfones |
| 04/24/2008 | US20080096948 Serotonin antagonist compositions and methods for the local inhibition of pain and inflammation |
| 04/24/2008 | US20080096910 Rapid release mini-tablets provide analgesia in laboratory animals |
| 04/24/2008 | US20080096858 Which is in an amorphous or other disordered state; freeze drying to remove water, heating within a given temperature range, optionally holding at heated temperature for up to two weeks, cooling |
| 04/24/2008 | US20080096854 Orally administering edible oil homogenized with edible wax and a sterol comprising stigmasterol, campesterol, p-sitosterol, chalinosterol, clionasterol, brassicasterol, alpha -spinasterol, daucosterol, desmosterol, and poriferasterol to treat colorectal, stomach, and/or esophagus cancer |
| 04/24/2008 | US20080096852 Use of oculosurface selective glucocorticoid in the treatment of dry eye |
| 04/24/2008 | US20080096841 Using analogs of Lipid A such as Eritoran to treat or prevent mucositis, allograft/graft rejection, arteriosclerosis, atherosclerosis, hepatitis, asthma, and inflammatory bowel disease |
| 04/24/2008 | US20080096818 administering polypeptides comprising beta amyloid fragments, to induce immunogenic response against amyloid deposits; prophylaxios and therapy of Alzheimer's disease |
| 04/24/2008 | US20080096801 Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
| 04/24/2008 | US20080096800 Rapid mucosal gel or film insulin compositions |
| 04/24/2008 | US20080096185 Method for Eliminating potentially toxic and/or harmful substances |
| 04/24/2008 | US20080096153 Characterization of an Antibiotic Impregnated Delivery System as an Intracanal Medicament in Endodontic Therapy |
| 04/24/2008 | US20080095857 avidin-modified protein-based nanoparticles to which biotinylated antibodies are bound by forming a stable avidin-biotin complex; preferably human serum albumin is used as protein |
| 04/24/2008 | US20080095856 Encapsulated Nanoparticles for Drug Delivery |
| 04/24/2008 | US20080095855 Taste Masking Granules |
| 04/24/2008 | US20080095854 Ballast administering to mammals skins; high density core overcoated with amorphous reservoir containing dna; drug delivery; containing free radical scavenger |
| 04/24/2008 | US20080095853 Modified Release For Proton Pump Inhibitors |
| 04/24/2008 | US20080095852 exposing a catalyst to a reagent in the presence of a core particle, whereby the reagent reacts to form a layer on the core particle to form the layered nanoparticle |
| 04/24/2008 | US20080095851 Phospholipid-free, having a D50 particle size of less than 500 nm, and having a surface stabilizer; improved pharmacokinetic profiles and reduced fed/fasted variability |
| 04/24/2008 | US20080095850 produces homogeneous, free flowing, attrition resistant, uniform sized granules of etoricoxib for treating pain and inflammation in patients that cannot swallow a tablet |
| 04/24/2008 | US20080095849 Peptide sustained release compositions and uses thereof |
| 04/24/2008 | US20080095848 Pharmaceutical Composition For Topical Use In Form Of Xerogels Or Films And Methods For Production |
| 04/24/2008 | US20080095847 Stimulus-release carrier, methods of manufacture and methods of treatment |
| 04/24/2008 | US20080095846 Pharmaceutical compositions of antihistamine and decongestant |
| 04/24/2008 | US20080095845 Comprises at least 60 weight % of an active ingredient and powdered wax having a melting point greater than 90 degrees C; produced by direct compression; has excellent disintegration |
| 04/24/2008 | US20080095844 Sustained release pharmaceutical compositions of alfuzosin and process for preparation thereof |
| 04/24/2008 | US20080095843 Controlled-release formulations |
| 04/24/2008 | US20080095842 Rapidly Disintegrating Taste Masked Compositions and a Process for Its Preparations |
| 04/24/2008 | US20080095841 Such as amlodipine besylate, iron oxide and carrageenan; storage stability |
| 04/24/2008 | US20080095840 Osmotic pumps; drug-layer (hydrophilic polyvinylpyrrolidone) and push-layer (osmopolymers) |
| 04/24/2008 | US20080095839 Core contains acid-unstable drug and disintegrant, and release-controlling coating contains water-insoluble polymer, an enteric polymer and hydrophobic wax |
| 04/24/2008 | US20080095838 Solid pharmaceutical composition containing a lipophilic active principle and preparation method thereof |
| 04/24/2008 | US20080095837 Human growth hormone formulations |
| 04/24/2008 | US20080095836 Glutathione-based delivery system |
| 04/24/2008 | US20080095835 Cyclin dependent kinase inhibitors; gene expression inhibition; cell differentiation; immunotherapy; cytokines |
| 04/24/2008 | US20080095834 Mitochondriotropic Phospholipid Vesicles |
| 04/24/2008 | US20080095833 Immunogens; expression cassettes; gag genes; tat proteins; DNA vaccines; vpr genes; rev genes; envelope genes; antigen presenting cells; liposomes |
| 04/24/2008 | US20080095832 Prosaposin as a neurotrophic factor |
| 04/24/2008 | US20080095831 Topical formulation of multilamellar vesicles composition for percutaneous absorption of pharmaceutically active agent |
| 04/24/2008 | US20080095829 Antimicrobial composites, films, labelstocks and labels |
| 04/24/2008 | US20080095828 Nonwoven webs; controlled/enhanced foam delivery |
| 04/24/2008 | US20080095827 Nutritional weight loss agent and method |
| 04/24/2008 | US20080095824 Delivery of drugs from sustained release devices implanted in myocardial tissue or in the pericardial space |
| 04/24/2008 | US20080095821 Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response |
| 04/24/2008 | US20080095812 Systems providing antimicrobial activity to an environment |
| 04/24/2008 | US20080095810 Nanoparticle systems for release of biologically active molecules formed by chitosan polymer or derivatives, chemically modified with polyethylene glycol and crosslinked with a crosslinking agent; especially useful for pharmaceutical compositions, vaccines and cosmetic formulations; controlled release |
| 04/24/2008 | US20080095806 Composition And Method For Treating Inflammatory Diseases Using Protease Inhibitors |
| 04/24/2008 | US20080095800 Eliciting HCV-specific antibodies |
| 04/24/2008 | US20080095786 Compositions And Methods For Preventing And Treating Endotoxin-Related Diseases And Conditions |
| 04/24/2008 | US20080095760 Using fibrinolytic metalloproteinase composition to treat and prevent cardiovascular disorders |
| 04/24/2008 | US20080095748 Biological matrix for use in tissue regeneration |
| 04/24/2008 | US20080095736 Biocompatible polymers and hydrogels and methods of use |
| 04/24/2008 | US20080095718 Atomizing a phosphodiesterase inhibitor, receptor agonists of dopamine, melaocortin, or growth hormone-releasing peptide, or an alpha-adrenoceptor antagonist; with a hand-held delivery device; increased bioavailability; side effect reduction |
| 04/24/2008 | US20080095717 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics |
| 04/24/2008 | US20080095716 A sterile and nonflammable mixture of carbon dioxide and oxygen suitable for producing microbubbles in a foaming liquid containing a sclerosing agent; contrast agents for ultrasounds; side effect reduction; nontoxic |
| 04/24/2008 | US20080095699 Imaging contrast agents using nanoparticles |
| 04/24/2008 | US20080094573 Surface-modified materials, such as contact lenses, methods and kits for their preparation, and uses thereof |
| 04/24/2008 | DE102006049929A1 Filmbildende Gelkomposition zur Wund- bzw. Hautpflege The film-forming gel composition for wound and skin care |
| 04/24/2008 | DE102006049837A1 Use of core-shell or hollow microparticles containing superparamagnetic nanoparticles to treat blood vessel defects by application of a magnetic field |
| 04/24/2008 | DE102006049675A1 Hautfreundliche W/O-Emulsionen Skin-friendly W / O emulsions |
| 04/24/2008 | DE102006049672A1 Hautfreundliche W/O-Emulsionen Skin-friendly W / O emulsions |
| 04/24/2008 | CA2675500A1 Ophthalmic compositions comprising diglycine |
| 04/24/2008 | CA2675499A1 Ophthalmic compositions containing diglycine |
| 04/24/2008 | CA2674917A1 Process for preparing oxymorphone, naltrexone, and buprenorphine |
| 04/24/2008 | CA2673646A1 Formation of medically useful gels comprising microporous particles and methods of use |
| 04/24/2008 | CA2673526A1 Phenylalkyl carbamate compositions |
| 04/24/2008 | CA2673487A1 Phenylalkylamino carbamate compositions |
| 04/24/2008 | CA2672925A1 Escitalopram and solid pharmaceutical composition comprising the same |
| 04/24/2008 | CA2670690A1 Pharmaceutical composition in the form of coated microspheres for the modified release of a muscle relaxant and an nsaid |
| 04/24/2008 | CA2670355A1 Polymer particles for delivery of macromolecules and methods of use |
| 04/24/2008 | CA2667039A1 Multiple unit tablet compositions of benzimidazole compounds |
| 04/24/2008 | CA2666587A1 Micellar nanoparticles of chemical substances |
| 04/24/2008 | CA2666581A1 Buprenorphine-containing non-pressurised spray composition for transmucosal administration |
| 04/24/2008 | CA2666398A1 Diclofenac gel |
| 04/24/2008 | CA2666077A1 Adhesive label with bittering agent and fluidifying agents for natural airway secretions |
| 04/23/2008 | EP1913957A1 Adjuvanted genetic vaccines |
| 04/23/2008 | EP1913956A1 Compositons and methods for stablizing biological molecules upon lyophilization |
| 04/23/2008 | EP1913948A1 Re-epithelializing pharmaceutical compositions containing xanthan gum |
| 04/23/2008 | EP1913945A2 Composition based on a thiazolidinedione and metformin and its use |
| 04/23/2008 | EP1913939A1 Formulations for use in inhaler devices |
| 04/23/2008 | EP1913938A1 Transdermal buprenorphine dosage regimen for analgesia |
| 04/23/2008 | EP1913937A1 Guaifenesin sustained release formulation and tablets |